Q3V129 AF NFT

Serine/threonine-protein kinase ULK4

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiacqmygrkmb7tpekaxynlivfkotdxseyciihx7l3fs7bkjoembrrm/metadata.json
IPFS of structure file: 
bafybeicrwiwq22lc35tq5imxsun4yjlfpjzetdm64plk7selnfao3r4wtq/AF-Q3V129-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x61B20aA3665705659d01e857CF16dedE7882E4F5
First NFT owner address (bech32): 
genesis1vxeq4gmx2uzkt8gpaptu79k7meug9e84c5rpd4
Current NFT ID #488479 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
488479
Accession (UniProt):
Q3V129
Name::
Serine/threonine-protein kinase ULK4
Experimental Method:
Predicted structure
Sequence source:
MUS MUSCULUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q3V129 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q3V129|ULK4_MOUSE Serine/threonine-protein kinase ULK4 OS=Mus musculus OX=10090 GN=Ulk4 PE=1 SV=2 MENFVLYEEIGRGSRTVVYKGRRKGTINFVAILCTEKCKRPEITNWVRLTHEIKHKNIVTFHEWYETSNHLWLVVELCTGGSLETVIAQDENLPEDVVREFGVDLVTGLHHLHRLGILFCDLSPGKILLEGPGTLKFSNFCLAKVAGESLEEFFALVAAEEGGGDSGENALKKSMKTRVRGSLIYAAPEIVKGTEFSVTSDLWSLGCLLYEMFSGKPPFFSETVSELVEKILYEDPLPPIPKDSSFPKASSDFLNLLDGLLQKDPQKRFSWEGVLQHPFWKDALRGEDSGWASEDSPFSRNVMECSGPHDSRELLQSPKNGQAKGQKAAHRLSQSFRLENPTELRPKSIMGGQLNESIFLLSSRPTPRTSAMVELNPGEGEDPSSPQKTSPLSKMTSGHLSQGALESQMRELIYTDSDLVITPIIDNPKIMKQPAIKFDPKILHLPAYSVEKLLVLKDQDWNDFLQQVCSQIDSSEKSTGALRAKLNLLCYLCVVATHKEVATRLLHSPLFQLLIQHLRIAPNWDIRSKVARVVGMLALHTTELQENVPVIEAITLLTELIRENFRSGKLKQCLLPTLGQLLYLVATQEEKNQHSRDCWAVPLAAYTVLMRCLREGEERVVNHMAAKIIENVCTTFSAQAQGFTTGEIGPVLWHLFRHSTVDALRITAISALCRITRQSPTAFQNVIEKVGLNAVISSLASAICKVQQYMLTLFTAMLSCGIHLQRLIQEKDFVSTVIRLLDSPSTPIRAKAFLVLLYILIHNRDMLLLSCQARLVMYIERDSRKTSPGKEQQSGNEYLARCLDLLIQHMVQEPPRILGDILNALANVSGRKHPSTVQGKQLKMCLPMMPVVLHLVMSQVFRPQVVTEEFLFSYGTILSHIKSIDLGETNIDGAIGIVASEEFIKVTLSAFEAVIQYPVLLADYRSTVMDYILPPLVSLVQSQNVEWRLFSLRLLSETTTLLVSQEPEDGDEEASCDSDSSLLALIRDELLPQYEHILMEPDPVPAYALKLLVAMTEHNPAFTRLVEESKLVPLIFEVILEHQESILGNTMQSVIALLNNLVAYKDSNMQLLYEQGLVGHVCNMFTETATLCLDRDNKTNTEPASTLLASLLDILLGMLTYTSRIVRQALQVQKSGSRGDTQAAEDLLLLSKPLTDLISLLIPLLPSEDPEISEVSSKCLSILVQLYGGENPESLSPENMVTFANLLMTKEDPKDQKLLLRILKRMVTSNERLLESLKNTGSLLQALERLAPAHRLRGPWAGISCALFQQRAAAQGIPELPPYGIPCCGPSHKRVTGVKLYPC